No matter what you may think about the United Kingdom’s plans to leave the European Union, there is one aspect that bears no controversy: Brexit will have a major impact on the pharmaceutical and biopharmaceutical industry worldwide, and there is no uncertainty that all participants in the supply chain for investigational medicinal products (IMPs) will…